Search

Search Constraints

You searched for: Author/Creator Durando, Xavier

Search Results

1. Aggressive Silent GH Pituitary Tumor Resistant to Multiple Treatments, Including Temozolomide. (19th March 2013)

2. Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas. (13th October 2015)

3. Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?. Issue 1 (July 2015)

5. Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors. (September 2022)

6. Long‐term Significance (15 years) of Pathological Complete Response after Dose‐dense Neoadjuvant Chemotherapy in Breast Cancer. Issue 4 (11th June 2013)

7. Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first‐line treatment of metastatic castration‐resistant prostate cancer. (5th March 2021)

8. PERCEPTION Trial protocol: Comparison of predictive and prognostic capacities of neutrophil, lymphocyte, and platelet counts and tumor-infiltrating lymphocytes in triple negative breast cancer. Issue 50 (11th December 2020)

9. Prognostic value of health‐related quality of life for death risk stratification in patients with unresectable glioblastoma. (1st June 2016)

10. Prospective Study on Body Composition, Energy Balance and Biological Factors Changes in Post-menopausal Women with Breast Cancer Receiving Adjuvant Chemotherapy Including Taxanes. (3rd October 2018)